Table of Contents 1 Market Overview 1.1 ENT Disorder Treatment Introduction 1.2 Market Analysis by Type 1.2.1 Tonsillitis 1.2.2 Ear Infections 1.2.3 Sinus Infections 1.2.4 Sleep Apnea 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Ambulatory Surgical Centers 1.3.4 Home Care Settings 1.3.5 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 AstraZeneca 2.1.1 Business Overview 2.1.2 ENT Disorder Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AstraZeneca ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Novartis 2.2.1 Business Overview 2.2.2 ENT Disorder Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Novartis ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Pfizer 2.3.1 Business Overview 2.3.2 ENT Disorder Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Pfizer ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Mylan 2.4.1 Business Overview 2.4.2 ENT Disorder Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Mylan ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Teva Pharmaceutical 2.5.1 Business Overview 2.5.2 ENT Disorder Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Teva Pharmaceutical ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 GlaxoSmithKline 2.6.1 Business Overview 2.6.2 ENT Disorder Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 GlaxoSmithKline ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Otonomy 2.7.1 Business Overview 2.7.2 ENT Disorder Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Otonomy ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Merck 2.8.1 Business Overview 2.8.2 ENT Disorder Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Merck ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Reddy’s 2.9.1 Business Overview 2.9.2 ENT Disorder Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Reddy’s ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Allergen 2.10.1 Business Overview 2.10.2 ENT Disorder Treatment Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Allergen ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global ENT Disorder Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global ENT Disorder Treatment Sales and Market Share by Manufacturer (2016-2017) 3.2 Global ENT Disorder Treatment Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 ENT Disorder Treatment Manufacturer Market Share in 2017 3.3.2 Top 6 ENT Disorder Treatment Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global ENT Disorder Treatment Market Analysis by Regions 4.1 Global ENT Disorder Treatment Sales, Revenue and Market Share by Regions 4.1.1 Global ENT Disorder Treatment Sales and Market Share by Regions (2013-2018) 4.1.2 Global ENT Disorder Treatment Revenue and Market Share by Regions (2013-2018) 4.2 North America ENT Disorder Treatment Sales and Growth Rate (2013-2018) 4.3 Europe ENT Disorder Treatment Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific ENT Disorder Treatment Sales and Growth Rate (2013-2018) 4.5 South America ENT Disorder Treatment Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa ENT Disorder Treatment Sales and Growth Rate (2013-2018) 5 North America ENT Disorder Treatment by Countries 5.1 North America ENT Disorder Treatment Sales, Revenue and Market Share by Countries 5.1.1 North America ENT Disorder Treatment Sales and Market Share by Countries (2013-2018) 5.1.2 North America ENT Disorder Treatment Revenue and Market Share by Countries (2013-2018) 5.2 United States ENT Disorder Treatment Sales and Growth Rate (2013-2018) 5.3 Canada ENT Disorder Treatment Sales and Growth Rate (2013-2018) 5.4 Mexico ENT Disorder Treatment Sales and Growth Rate (2013-2018) 6 Europe ENT Disorder Treatment by Countries 6.1 Europe ENT Disorder Treatment Sales, Revenue and Market Share by Countries 6.1.1 Europe ENT Disorder Treatment Sales and Market Share by Countries (2013-2018) 6.1.2 Europe ENT Disorder Treatment Revenue and Market Share by Countries (2013-2018) 6.2 Germany ENT Disorder Treatment Sales and Growth Rate (2013-2018) 6.3 UK ENT Disorder Treatment Sales and Growth Rate (2013-2018) 6.4 France ENT Disorder Treatment Sales and Growth Rate (2013-2018) 6.5 Russia ENT Disorder Treatment Sales and Growth Rate (2013-2018) 6.6 Italy ENT Disorder Treatment Sales and Growth Rate (2013-2018) 7 Asia-Pacific ENT Disorder Treatment by Countries 7.1 Asia-Pacific ENT Disorder Treatment Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific ENT Disorder Treatment Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific ENT Disorder Treatment Revenue and Market Share by Countries (2013-2018) 7.2 China ENT Disorder Treatment Sales and Growth Rate (2013-2018) 7.3 Japan ENT Disorder Treatment Sales and Growth Rate (2013-2018) 7.4 Korea ENT Disorder Treatment Sales and Growth Rate (2013-2018) 7.5 India ENT Disorder Treatment Sales and Growth Rate (2013-2018) 7.6 Southeast Asia ENT Disorder Treatment Sales and Growth Rate (2013-2018) 8 South America ENT Disorder Treatment by Countries 8.1 South America ENT Disorder Treatment Sales, Revenue and Market Share by Countries 8.1.1 South America ENT Disorder Treatment Sales and Market Share by Countries (2013-2018) 8.1.2 South America ENT Disorder Treatment Revenue and Market Share by Countries (2013-2018) 8.2 Brazil ENT Disorder Treatment Sales and Growth Rate (2013-2018) 8.3 Argentina ENT Disorder Treatment Sales and Growth Rate (2013-2018) 8.4 Colombia ENT Disorder Treatment Sales and Growth Rate (2013-2018) 9 Middle East and Africa ENT Disorder Treatment by Countries 9.1 Middle East and Africa ENT Disorder Treatment Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa ENT Disorder Treatment Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa ENT Disorder Treatment Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia ENT Disorder Treatment Sales and Growth Rate (2013-2018) 9.3 UAE ENT Disorder Treatment Sales and Growth Rate (2013-2018) 9.4 Egypt ENT Disorder Treatment Sales and Growth Rate (2013-2018) 9.5 Nigeria ENT Disorder Treatment Sales and Growth Rate (2013-2018) 9.6 South Africa ENT Disorder Treatment Sales and Growth Rate (2013-2018) 10 Global ENT Disorder Treatment Market Segment by Type 10.1 Global ENT Disorder Treatment Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global ENT Disorder Treatment Sales and Market Share by Type (2013-2018) 10.1.2 Global ENT Disorder Treatment Revenue and Market Share by Type (2013-2018) 10.2 Tonsillitis Sales Growth and Price 10.2.1 Global Tonsillitis Sales Growth (2013-2018) 10.2.2 Global Tonsillitis Price (2013-2018) 10.3 Ear Infections Sales Growth and Price 10.3.1 Global Ear Infections Sales Growth (2013-2018) 10.3.2 Global Ear Infections Price (2013-2018) 10.4 Sinus Infections Sales Growth and Price 10.4.1 Global Sinus Infections Sales Growth (2013-2018) 10.4.2 Global Sinus Infections Price (2013-2018) 10.5 Sleep Apnea Sales Growth and Price 10.5.1 Global Sleep Apnea Sales Growth (2013-2018) 10.5.2 Global Sleep Apnea Price (2013-2018) 11 Global ENT Disorder Treatment Market Segment by Application 11.1 Global ENT Disorder Treatment Sales Market Share by Application (2013-2018) 11.2 Hospitals Sales Growth (2013-2018) 11.3 Clinics Sales Growth (2013-2018) 11.4 Ambulatory Surgical Centers Sales Growth (2013-2018) 11.5 Home Care Settings Sales Growth (2013-2018) 11.6 Others Sales Growth (2013-2018) 12 ENT Disorder Treatment Market Forecast (2018-2023) 12.1 Global ENT Disorder Treatment Sales, Revenue and Growth Rate (2018-2023) 12.2 ENT Disorder Treatment Market Forecast by Regions (2018-2023) 12.2.1 North America ENT Disorder Treatment Market Forecast (2018-2023) 12.2.2 Europe ENT Disorder Treatment Market Forecast (2018-2023) 12.2.3 Asia-Pacific ENT Disorder Treatment Market Forecast (2018-2023) 12.2.4 South America ENT Disorder Treatment Market Forecast (2018-2023) 12.2.5 Middle East and Africa ENT Disorder Treatment Market Forecast (2018-2023) 12.3 ENT Disorder Treatment Market Forecast by Type (2018-2023) 12.3.1 Global ENT Disorder Treatment Sales Forecast by Type (2018-2023) 12.3.2 Global ENT Disorder Treatment Market Share Forecast by Type (2018-2023) 12.4 ENT Disorder Treatment Market Forecast by Application (2018-2023) 12.4.1 Global ENT Disorder Treatment Sales Forecast by Application (2018-2023) 12.4.2 Global ENT Disorder Treatment Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure ENT Disorder Treatment Picture Table Product Specifications of ENT Disorder Treatment Figure Global Sales Market Share of ENT Disorder Treatment by Types in 2017 Table ENT Disorder Treatment Types for Major Manufacturers Figure Tonsillitis Picture Figure Ear Infections Picture Figure Sinus Infections Picture Figure Sleep Apnea Picture Figure ENT Disorder Treatment Sales Market Share by Applications in 2017 Figure Hospitals Picture Figure Clinics Picture Figure Ambulatory Surgical Centers Picture Figure Home Care Settings Picture Figure Others Picture Figure United States ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Canada ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Mexico ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Germany ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure France ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure UK ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Russia ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Italy ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure China ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Japan ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Korea ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure India ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Brazil ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Egypt ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure South Africa ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria ENT Disorder Treatment Revenue (Value) and Growth Rate (2013-2023) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca ENT Disorder Treatment Type and Applications Table AstraZeneca ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis ENT Disorder Treatment Type and Applications Table Novartis ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer ENT Disorder Treatment Type and Applications Table Pfizer ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Mylan Basic Information, Manufacturing Base and Competitors Table Mylan ENT Disorder Treatment Type and Applications Table Mylan ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical ENT Disorder Treatment Type and Applications Table Teva Pharmaceutical ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline ENT Disorder Treatment Type and Applications Table GlaxoSmithKline ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Otonomy Basic Information, Manufacturing Base and Competitors Table Otonomy ENT Disorder Treatment Type and Applications Table Otonomy ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck ENT Disorder Treatment Type and Applications Table Merck ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Reddy’s Basic Information, Manufacturing Base and Competitors Table Reddy’s ENT Disorder Treatment Type and Applications Table Reddy’s ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Allergen Basic Information, Manufacturing Base and Competitors Table Allergen ENT Disorder Treatment Type and Applications Table Allergen ENT Disorder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global ENT Disorder Treatment Sales by Manufacturer (2016-2017) Figure Global ENT Disorder Treatment Sales Market Share by Manufacturer in 2016 Figure Global ENT Disorder Treatment Sales Market Share by Manufacturer in 2017 Table Global ENT Disorder Treatment Revenue by Manufacturer (2016-2017) Figure Global ENT Disorder Treatment Revenue Market Share by Manufacturer in 2016 Figure Global ENT Disorder Treatment Revenue Market Share by Manufacturer in 2017 Figure Top 3 ENT Disorder Treatment Manufacturer (Revenue) Market Share in 2017 Figure Top 6 ENT Disorder Treatment Manufacturer (Revenue) Market Share in 2017 Figure Global ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Global ENT Disorder Treatment Revenue and Growth Rate (2013-2018) Table Global ENT Disorder Treatment Sales by Regions (2013-2018) Table Global ENT Disorder Treatment Sales Market Share by Regions (2013-2018) Table Global ENT Disorder Treatment Revenue by Regions (2013-2018) Figure Global ENT Disorder Treatment Revenue Market Share by Regions in 2013 Figure Global ENT Disorder Treatment Revenue Market Share by Regions in 2017 Figure North America ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Europe ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Asia-Pacific ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure South America ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Middle East and Africa ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure North America ENT Disorder Treatment Revenue and Growth Rate (2013-2018) Table North America ENT Disorder Treatment Sales by Countries (2013-2018) Table North America ENT Disorder Treatment Sales Market Share by Countries (2013-2018) Figure North America ENT Disorder Treatment Sales Market Share by Countries in 2013 Figure North America ENT Disorder Treatment Sales Market Share by Countries in 2017 Table North America ENT Disorder Treatment Revenue by Countries (2013-2018) Table North America ENT Disorder Treatment Revenue Market Share by Countries (2013-2018) Figure North America ENT Disorder Treatment Revenue Market Share by Countries in 2013 Figure North America ENT Disorder Treatment Revenue Market Share by Countries in 2017 Figure United States ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Canada ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Mexico ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Europe ENT Disorder Treatment Revenue and Growth Rate (2013-2018) Table Europe ENT Disorder Treatment Sales by Countries (2013-2018) Table Europe ENT Disorder Treatment Sales Market Share by Countries (2013-2018) Table Europe ENT Disorder Treatment Revenue by Countries (2013-2018) Figure Europe ENT Disorder Treatment Revenue Market Share by Countries in 2016 Figure Europe ENT Disorder Treatment Revenue Market Share by Countries in 2017 Figure Germany ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure UK ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure France ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Russia ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Italy ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Asia-Pacific ENT Disorder Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific ENT Disorder Treatment Sales by Countries (2013-2018) Table Asia-Pacific ENT Disorder Treatment Sales Market Share by Countries (2013-2018) Figure Asia-Pacific ENT Disorder Treatment Sales Market Share by Countries 2017 Table Asia-Pacific ENT Disorder Treatment Revenue by Countries (2013-2018) Figure Asia-Pacific ENT Disorder Treatment Revenue Market Share by Countries 2017 Figure China ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Japan ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Korea ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure India ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Southeast Asia ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure South America ENT Disorder Treatment Revenue and Growth Rate (2013-2018) Table South America ENT Disorder Treatment Sales by Countries (2013-2018) Table South America ENT Disorder Treatment Sales Market Share by Countries (2013-2018) Figure South America ENT Disorder Treatment Sales Market Share by Countries in 2017 Table South America ENT Disorder Treatment Revenue by Countries (2013-2018) Table South America ENT Disorder Treatment Revenue Market Share by Countries (2013-2018) Figure South America ENT Disorder Treatment Revenue Market Share by Countries in 2017 Figure Brazil ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Argentina ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Colombia ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Middle East and Africa ENT Disorder Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa ENT Disorder Treatment Sales by Countries (2013-2018) Table Middle East and Africa ENT Disorder Treatment Sales Market Share by Countries (2013-2018) Figure Middle East and Africa ENT Disorder Treatment Sales Market Share by Countries in 2017 Table Middle East and Africa ENT Disorder Treatment Revenue by Countries (2013-2018) Table Middle East and Africa ENT Disorder Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa ENT Disorder Treatment Revenue Market Share by Countries in 2013 Figure Middle East and Africa ENT Disorder Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure UAE ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Egypt ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure Nigeria ENT Disorder Treatment Sales and Growth Rate (2013-2018) Figure South Africa ENT Disorder Treatment Sales and Growth Rate (2013-2018) Table Global ENT Disorder Treatment Sales by Type (2013-2018) Table Global ENT Disorder Treatment Sales Share by Type (2013-2018) Table Global ENT Disorder Treatment Revenue by Type (2013-2018) Table Global ENT Disorder Treatment Revenue Share by Type (2013-2018) Figure Global Tonsillitis Sales Growth (2013-2018) Figure Global Tonsillitis Price (2013-2018) Figure Global Ear Infections Sales Growth (2013-2018) Figure Global Ear Infections Price (2013-2018) Figure Global Sinus Infections Sales Growth (2013-2018) Figure Global Sinus Infections Price (2013-2018) Figure Global Sleep Apnea Sales Growth (2013-2018) Figure Global Sleep Apnea Price (2013-2018) Table Global ENT Disorder Treatment Sales by Application (2013-2018) Table Global ENT Disorder Treatment Sales Share by Application (2013-2018) Figure Global Clinics Sales Growth (2013-2018) Figure Global Ambulatory Surgical Centers Sales Growth (2013-2018) Figure Global Home Care Settings Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global ENT Disorder Treatment Sales, Revenue and Growth Rate (2018-2023) Table Global ENT Disorder Treatment Sales Forecast by Regions (2018-2023) Table Global ENT Disorder Treatment Market Share Forecast by Regions (2018-2023) Figure North America Sales ENT Disorder Treatment Market Forecast (2018-2023) Figure Europe Sales ENT Disorder Treatment Market Forecast (2018-2023) Figure Asia-Pacific Sales ENT Disorder Treatment Market Forecast (2018-2023) Figure South America Sales ENT Disorder Treatment Market Forecast (2018-2023) Figure Middle East and Africa Sales ENT Disorder Treatment Market Forecast (2018-2023) Table Global ENT Disorder Treatment Sales Forecast by Type (2018-2023) Table Global ENT Disorder Treatment Market Share Forecast by Type (2018-2023) Table Global ENT Disorder Treatment Sales Forecast by Application (2018-2023) Table Global ENT Disorder Treatment Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

AstraZeneca Novartis Pfizer Mylan Teva Pharmaceutical GlaxoSmithKline Otonomy Merck Reddy’s Allergen